TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Dating Sites: Best, Worst & Weirdest
OPINION

Allergan's Healthy Prospects

  • By Marc Courtenay
  • Feb 8, 2013 6:00 AM EST
Dating Sites: Best, Worst & Weirdest
OPINION

Cramer's 6 Stocks in 60 Seconds: SNV TXN UL CREE MAPP KBH (Update 1)

  • By Scott Rutt
  • Jan 23, 2013 5:07 PM EST
Looking at Mannkind's Afrezza Sales Estimates Ahead of Sanofi Earnings
STOCKS

2013 FDA Drug Approval Decision Calendar

  • By Adam Feuerstein
  • Dec 19, 2012 9:12 AM EST
Gilead: Hepatitis C Sales Guidance for 2015 Focus of Tuesday's Earnings Report
STOCKS

Biotech Stock Mailbag: Aveo, Anthera, Amarin, MAP Pharma

  • By Adam Feuerstein
  • Nov 20, 2012 10:17 AM EST
Galapagos Receives a Rousing Welcome on Its First Day of Trading
STOCKS

MAP Pharma's Awkward FDA Silence

  • By Adam Feuerstein
  • Nov 14, 2012 9:14 AM EST
3 Basic Materials Stocks Driving The Sector Higher
MARKETS

MAP Pharmaceuticals Inc. Stock Downgraded (MAPP)

  • By TheStreet Wire
  • Apr 13, 2012 6:00 AM EDT
Analysts' Actions: Bristol-Myers, Broadcom, Jabil Circuit and More
STOCKS

Analysts' Actions: ARIA, EA, HGSI, BBBY

  • By TheStreet Staff
  • Apr 12, 2012 8:46 AM EDT
Insider Trading Alert - RYL, BHB And AAL Traded By Insiders
MARKETS

MAP Pharmaceuticals Inc. Stock Downgraded (MAPP)

  • By TheStreet Wire
  • Apr 2, 2012 4:09 AM EDT
MannKind Afrezza Contributes to Sanofi's Subpar Diabetes Unit Sales
STOCKS

Biotech Stock Mailbag: MAP Pharma, Affymax

  • By Adam Feuerstein
  • Mar 30, 2012 5:30 AM EDT
Horizon Goes Hostile With $3 Billion Takeout Offer for Depomed
STOCKS

Signs Point to MAP Pharma Drug Rejection

  • By Adam Feuerstein
  • Mar 26, 2012 4:15 PM EDT
Jones Lang LaSalle (JLL) Reaches New Lifetime High Today
MARKETS

MAP Pharmaceuticals Inc. Stock Upgraded (MAPP)

  • By TheStreet Wire
  • Mar 26, 2012 6:09 AM EDT
Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest
STOCKS

Biotech Stock Mailbag: Xoma's Big Backers, FDA Approvals Contest

  • By Adam Feuerstein
  • Mar 23, 2012 5:30 AM EDT
The Next Big Thing in Biotech: FDA Decisions
VIDEO

The Next Big Thing in Biotech: FDA Decisions

  • By Gregg Greenberg
  • Mar 23, 2012 5:00 AM EDT
Hedge Funds Love These 5 Consumer Stocks -- but Should You?
INVESTING

8 Stocks Rising on Huge Volume

  • By Roberto Pedone
  • Mar 19, 2012 12:54 PM EDT
Vertex Pharma Cystic Fibrosis FDA Advisory Panel Live Blog
INVESTING

Biotech Stock Chat: Recap

  • By Adam Feuerstein
  • Mar 15, 2012 11:54 AM EDT
Gilead: Hepatitis C Sales Guidance for 2015 Focus of Tuesday's Earnings Report
STOCKS

These Drugs Stocks Will Win FDA Approval

  • By Adam Feuerstein
  • Feb 16, 2012 12:04 PM EST
Genfit Tortures Fatty Liver Drug to Extract Positive Results From Failed Study
STOCKS

Play TheStreet's FDA Drug-Approval Contest

  • By Adam Feuerstein
  • Jan 23, 2012 8:14 AM EST
5 Stocks Under $10 Making Big Moves: Rex Energy, Corinthian Colleges and More
INVESTING

8 Stocks Rising on Unusual Volume

  • By Roberto Pedone
  • Dec 19, 2011 12:39 PM EST
Ampio's Eye Drug Approval Strategy Dealt Another Credibility Hit
STOCKS

27 Hot Drugs Facing FDA Approval in 2012

  • By Adam Feuerstein
  • Dec 19, 2011 10:50 AM EST
Insider Trading Alert - RYL, BHB And AAL Traded By Insiders
MARKETS

MAP Pharmaceuticals Inc. Stock Upgraded (MAPP)

  • By TheStreet Wire
  • Nov 10, 2011 5:01 AM EST
Galapagos Receives a Rousing Welcome on Its First Day of Trading
STOCKS

Biotech Calendar: 2011-12 FDA Drug Approvals

  • By Adam Feuerstein
  • Aug 11, 2011 10:39 AM EDT
Galapagos Receives a Rousing Welcome on Its First Day of Trading
STOCKS

Biotech Calendar: 2011 FDA Drug Approvals

  • By Adam Feuerstein
  • Feb 22, 2011 7:36 AM EST
ASCO 2012 Live Blog -- Saturday
INVESTING

J.P. Morgan Healthcare Confab: Live Blog

  • By Adam Feuerstein
  • Jan 11, 2011 4:57 PM EST
Dating Sites: Best, Worst & Weirdest
OPINION

BVF Sells $2.4M Worth of Ligand Pharma

  • By Jonathan Moreland
  • Jun 30, 2009 1:06 PM EDT
Dating Sites: Best, Worst & Weirdest
OPINION

Insider Sells $1.8M Worth of Verifone

  • By Jonathan Moreland
  • Jun 25, 2009 9:07 AM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.